|Denaro||0,00 x 1200|
|Lettera||0,00 x 1800|
|Min-Max giorno||331,01 - 341,73|
|Intervallo di 52 settimane||241,73 - 417,37|
|Beta (5 anni mensile)||1,16|
|Rapporto PE (ttm)||34,68|
|Prossima data utili||17 mar 2022|
|Rendimento e dividendo (forward)||3,88 (1,18%)|
|Data ex dividendo||12 gen 2022|
|Stima target 1A||N/D|
Accenture’s Q1 revenue beat and revised outlook for Q2 boosted shares over 11% in premarket trade.
Accenture’s shares are gaining steam ahead of the company’s fiscal first-quarter earnings report, which is due on Dec 16.
Key Drivers of Supply Chain Visibility Investments Quality assurance and improving customer experience are key drivers for enhancing security and visibility requirements Most Pressing Inbound Challenges Supplier manufacturing visibility and compliance remain the biggest pain points in pharma supply chain Pharma executives cite supply chain visibility as critical solution to alleviating product loss and security concerns, while one-third are dissatisfied with current solutions CHICAGO, Dec. 07, 2